RYELX
Price
$401.18
Change
+$2.40 (+0.60%)
Updated
Oct 17 closing price
SLMCX
Price
$132.73
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
Ad is loading...

RYELX vs SLMCX

Header iconRYELX vs SLMCX Comparison
Open Charts RYELX vs SLMCXBanner chart's image
Rydex Electronics A
Price$401.18
Change+$2.40 (+0.60%)
VolumeN/A
CapitalizationN/A
Columbia Seligman Tech & Info A
Price$132.73
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RYELX vs SLMCX Comparison Chart
Loading...
VS
RYELX vs. SLMCX commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYELX is a Buy and SLMCX is a Buy.

FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 13.6B vs. RYELX (111M). RYELX (0.00) and SLMCX (0.00) have matching dividends . RYELX was incepted earlier than SLMCX: RYELX (20 years) vs SLMCX (41 years). RYELX is a more actively managed with annual turnover of: 147.00 vs. SLMCX (13.00). SLMCX has a lower initial minimum investment than RYELX: SLMCX (2000) vs RYELX (2500). RYELX annual gain was more profitable for investors over the last year : 42.67 vs. SLMCX (27.03). RYELX return over 5 years is better than : 199.91 vs. SLMCX (70.82).
RYELXSLMCXRYELX / SLMCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years41 years-
Gain YTD20.77718.721111%
Front LoadN/AN/A-
Min. Initial Investment25002000125%
Min. Initial Investment IRAN/AN/A-
Net Assets111M13.6B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year42.6727.03158%
Returns for 3 years43.073.971,084%
Returns for 5 years199.9170.82282%
Returns for 10 years539.75146.16369%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RUNTX29.410.38
+1.31%
Russell Inv US Small Cap Equity M
SLVIX37.460.31
+0.83%
Columbia Select Large Cap Value Inst2
RRFDX38.520.28
+0.73%
T. Rowe Price Equity Income R
GFVAX16.73N/A
N/A
Goldman Sachs Focused Value A
NALFX69.57N/A
N/A
New Alternatives A